FIELD: organic chemistry.
SUBSTANCE: group of inventions includes a compound of formula (I), specific compounds listed in the claims, a method of preparing a compound of formula (I), the use of a compound of formula (I), a method of inhibiting MAGL, and a method of determining the MAGL inhibitory activity of a compound. In formula (I), X is C-R3; m is either 0 or 1; n is selected from 0, 1 and 2; and L is selected from -C≡C-, -CHR4-NR5-CH2-, -CH2-NR5-CHR4-, -(CR6R7)p-C(O)-NR8-, -C(O)-NR8-(CR6R7)p-, -(CR6R7)p-NR8-C(O)-, -(CH2)qNR9-, -S-, -S(O)-, -SO2-, -SCH2-, -CH2S-, -S(O)CH2- and -SO2CH2-; each of p and q is independently selected from 0, 1 and 2; A is selected from: (i) C6-C14-aryl substituted with R10, R11 and R12; (ii) 5–14-membered heteroaryl selected from thiophenyl and pyridinyl substituted with R13 and R14; and (iii) C3-C10-cycloalkyl substituted with R22; R1, R2 are hydrogen; R3 is selected from hydrogen, hydroxy and C1-6-alkyl; R4 is halo-C1-6-alkyl; R5 is selected from hydrogen and C1-6-alkyl; each of R6 and R7 independently represents hydrogen; or R6 and R7 together with the carbon atom to which they are attached form C3-10-cycloalkyl; R8 is selected from hydrogen, C1-6-alkyl and hydroxy-C1-6-alkyl; R9 is C1-6-alkyl; each of R10, R11, R12, R13 and R14 is independently selected from hydrogen, halogen, cyano, hydroxy, C1-6-alkyl, halo-C1-6-alkyl, C1-6-alkoxy, halo-C1-6-alkoxy, C1-6-alkylsulfonyl, C3-10-cycloalkyl optionally substituted with R19; R19 is independently selected from cyano and hydroxy; R22 is hydroxy.
EFFECT: compound of formula (I) with inhibitory activity against monoacylglycerol lipase (MAGL).
34 cl, 1 tbl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS | 2019 |
|
RU2769507C1 |
OXAZINMONOACYLGLYCERIN LIPASE (MAGL) INHIBITORS | 2019 |
|
RU2794334C2 |
HETEROCYCLIC COMPOUNDS | 2019 |
|
RU2809257C2 |
QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS | 2015 |
|
RU2721723C2 |
COMPOUND FOR DESTRUCTION OF ANDROGEN RECEPTOR AND ITS PHARMACEUTICAL USE THEREOF | 2021 |
|
RU2817356C1 |
BICYCLIC HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS | 2020 |
|
RU2811612C2 |
AVB6 INTEGRIN INHIBITORS | 2018 |
|
RU2769702C2 |
BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS | 2016 |
|
RU2738232C2 |
SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
NOVEL S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | 2011 |
|
RU2585763C2 |
Authors
Dates
2023-08-03—Published
2019-08-12—Filed